Goldman Sachs (GS) Laps the Stock Market: Here's Why

Goldman Sachs (GS) recently outperformed major indices, closing up 1.35% and gaining 2.09% over the past month, surpassing its sector and the S&P 500. The investment bank is scheduled to report Q3 earnings on October 14, 2025, with consensus estimates projecting robust year-over-year growth of 22.26% in EPS to $10.27 and 7.56% in revenue to $13.66 billion. With a Zacks Rank #2 (Buy) and a Forward P/E of 16.19—a discount to its industry—GS maintains a favorable outlook within a top-ranked industry, signaling potential continued strength.

Analysis

Goldman Sachs (GS) has demonstrated significant near-term strength, with its stock gaining 1.35% in the last session and 2.09% over the past month, outpacing both the S&P 500 and the broader Finance sector. This momentum is supported by strong forward-looking fundamentals ahead of its October 14, 2025, earnings report. Consensus estimates project robust quarterly earnings growth of 22.26% to $10.27 per share and revenue growth of 7.56% to $13.66 billion. On an annual basis, analysts expect a 12.56% increase in EPS and a 6.28% rise in revenue. From a valuation perspective, GS trades at a Forward P/E of 16.19, a slight discount to its industry average of 16.75, while its PEG ratio of 1.57 is in line with peers, suggesting its growth is not excessively priced. The bullish case is further reinforced by a Zacks Rank of #2 (Buy) and its position within an industry ranked in the top 5%. However, it is notable that consensus EPS estimates have remained unchanged over the last month, indicating that the current optimism is based on established, rather than recently upgraded, forecasts.

Key Decisions for Investors

• Given the strong earnings growth forecasts, recent market outperformance, and a slight valuation discount to peers, investors could view GS as a strong candidate for a long position ahead of its next earnings report.
• The primary focus for investors should be the October 14, 2025, earnings release, where meeting or exceeding the consensus EPS estimate of $10.27 will be critical to sustaining the stock's upward momentum.
• While the overall outlook is positive, the lack of recent upward analyst revisions suggests a need for caution, as the stock's performance is contingent on delivering on current high expectations rather than benefiting from newly raised forecasts.